Post-partum depression and low Vitamin D - many studies
Meta-analysis: 23% decrease in Postpartum Depression for 10 nmol Vitamin D increase - July 2026
Impact of Vitamin D during Pregnancy towards Postpartum Depression: A Meta-Analysis of Dose-response Association and Intervention
Trends Psychiatry Psychother 2026 Jul 23. doi: 10.47626/2237-6089-2025-1280
Samuel Partogi Nababan 1, Gresita Novelia Uirianto 1, Juan Fransiscus Wira 2, Whitney Joycelyn Tenaya 3, Deva Fitra Firdausa Anwar 4
Introduction: Serum vitamin D (25(OH)D) concentration has been associated with PPD in previous studies. However, whether there is a dose-response relationship and if its supplementation during pregnancy can improve symptoms after delivery remains unclear.
Methods: Five databases were searched on September 27, 2025. Cohort studies were included for dose-response meta-analysis (DRMA), while randomized controlled trials (RCTs) were included for meta-analysis (MA) of supplementation. The outcome for MA of supplementation was postpartum Edinburgh Postnatal Depression Scale (EPDS) score using the effect measure of mean difference (MD), while the outcome for DRMA was the odds ratio (OR) of PPD after delivery. Certainty was assessed using GRADE for MA of supplementation.
Results: Only two prospective cohort studies were included for DRMA and two RCTs were included for MA of supplementation. There was a significant log linear dose-response relationship between 25(OH)D serum concentration and developing PPD with β = -0.0256 (95% CI = -0.0454 to -0.0057). Every 10 nmol/L increase was associated with OR = 0.77 (95% CI = 0.63 to 0.94). Meta-analysis found a significant reduction in EPDS scores at 4 weeks after delivery (MD = -2.70; 95% CI = -3.68 to -1.71; low certainty).
Conclusion: Vitamin D serum concentration during pregnancy might be log linearly associated with developing PPD after delivery and its supplementation during pregnancy may improve PPD symptoms at 4 weeks postpartum. However, findings should be interpreted cautiously as evidence is limited to the small number of studies.
Only Vitamin D was found to treat post-partum depression - Meta-analysis April 2023
Dietary interventions for perinatal depression and anxiety: a systematic review and meta-analysis of randomized controlled trials
Am J Clin Nutr. 2023 Apr 3;S0002-9165(23)46315-0. doi: 10.1016/j.ajcnut.2023.03.025 PDF is behind a paywall
Zoe Tsai 1, Nirmay Shah 2, Umair Tahir 2, Neda Mortaji 3, Sawayra Owais 4, Maude Perreault 5, Ryan J Van Lieshout 3
Background: Dietary interventions are a widely available intervention for depression and anxiety among pregnant and/or postpartum (i.e., perinatal) persons but their effectiveness is not well known.
Objective: We performed a systematic review and meta-analysis to assess the effectiveness of dietary interventions for the treatment of perinatal depression and/or anxiety.
Design: We searched Medline, EMBASE, PsycINFO, CINAHL, and Web of Science from their inception to November 2, 2022. Studies were included if they were available in English and examined the effectiveness of a dietary intervention for perinatal depression and/or anxiety in a randomized controlled trial.
Results: Our search identified 4,246 articles, 36 of which were included and 28 were eligible for meta-analysis. Random effects meta-analyses were performed.
Polyunsaturated fatty acids (PUFAs) were not found to improve symptoms of perinatal depression compared to control conditions (SMD -0.11; 95% CI -0.26 to 0.04). These results did not change when examined during pregnancy or the postpartum period separately, nor did they vary according to fatty acid ratio.
Elemental metals (iron, zinc, and magnesium) were also not found to be superior to placebo (SMD, -0.42; 95% CI, -1.05 to 0.21), though,
vitamin D yielded a small to medium effect size improvements (SMD, -0.52; 95% CI, -0.84 to -0.20) in postpartum depression.
Iron may help in those with confirmed iron deficiency. Narrative synthesis was performed for studies ineligible for meta-analyses.
Conclusions: Despite their widespread popularity, PUFAs and elemental metals do not appear to effectively reduce perinatal depression. Vitamin D taken in doses of 1800 to 3500 International Units (IU) per day may have some promise. Additional high-quality, large-scale randomized controlled trials (RCTs) are needed to determine the true effectiveness of dietary interventions on perinatal depression and/or anxiety.
Omega-3 typically fights postpartum depression (ignores Omega-6) Jan 2024
A Critical Look at Omega-3 Supplementation: A Thematic Review
Healthcare 2023,11, 3065. https://doi.org/10.3390/ healthcare11233065
Yamil Liscano yamil.liscano00@usc.edu.co 1 0 and Natalia Sanchez-Palacio 2
Grupo de Investigación en Salud Integral (GISI), Departamento Facultad de Salud, Universidad Santiago de Cali, Cali 5183000, Colombia
Grupo de Investigación en Promoción de la Salud y Prevención de la Enfermedad, Universidad de Caldas, Manizales 170004, Colombia; natalia.sanchez@ucaldas.edu.co
Postpartum depression (PPD) affects 10-20% of women. Traditional treatments have raised concerns, but omega-3 fatty acids show potential as an alternative. This thematic review, sourced from databases like PubMed and Scopus between 1 February 2023 and 15 March 2023, seeks to delve into the various perspectives on omega-3 supplementation for PPD. The criteria included studies detailing depressive symptoms, social functioning, and neurobiological variables. The review includes research with women showing PPD symptoms, randomized clinical trials, and articles in Spanish, English, and French. Exclusions were studies lacking proper control comparisons and other interventions besides omega-3. Data extraction was performed independently. Two key studies provide contrasting findings on omega-3's impact on PPD symptoms. In the study comparing DHA supplementation to a placebo, significant differences were not found in the EPDS scale, but differences were observed in the BDI scale. In contrast, another study recorded a significant decrease in depression scores in all dose groups, with reductions of 51.5% in the EPDS scale and 48.8% in the HRSD scale. Other studies, encompassing both prenatal and postpartum periods, underscore the differentiation between prenatal depression and PPD. Despite shared diagnostic criteria, PPD presents unique symptoms like restlessness, emotional lability, and baby-related concerns. It is crucial to address biases and obtain specific results, recommending exclusive PPD-focused studies. This review emphasizes the need for continuous exploration of omega-3's relationship with PPD to enhance the life quality of pregnant women and their families.
📄 Download the PDF from VitaminDWiki
FDA announced fast-acting Zurzuvae pill for postpartum depression - Aug 2023
"The FDA warned that the drug’s side effects can include drowsiness, dizziness, fatigue, diarrhea, urinary tract infection and nasopharyngitis (the common cold)."
A persion "cautioned that Zurzuvae is not a “magic pill” for broadly solving postpartum depression."
To be fast acting, Vitamin D needs to start with a loading dose (otherwise it takes many months)
Millions of people have all successfully use Vitamin D loading doses.
There are an extremely wide variety of loading dose protocols, all of which work
50,000 IU of vitamin D daily for a week is one example
Hundreds of studies are compared at Overview Loading of vitamin D